BPC-157

BPC-157 is a synthetic peptide composed of a 15-amino-acid sequence corresponding to a partial fragment of a protein originally identified in gastric juice. Within the Healing & Recovery category, it is supplied in an injectable research format for licensed practitioner and laboratory use. It is among the more frequently referenced "body protection compound" peptides in the preclinical literature, where it has been examined in models of tissue and connective-tissue response. BPC-157 is not approved by the FDA for therapeutic use; it is provided strictly for research and professional reference purposes. This entry summarizes publicly available research framing only and is not a representation of clinical efficacy or safety. Individual results vary, and reported findings are preclinical and not predictive of human outcomes.

• Investigated in preclinical literature for tissue-repair and wound-healing response models (individual results vary)
• Studied in animal research relating to tendon, ligament, and musculoskeletal recovery processes (individual results vary)
• Examined in experimental gastrointestinal-tract integrity and mucosal-protection models (individual results vary)
• Referenced in research exploring angiogenesis and microvascular response (individual results vary)
• Investigated in preclinical studies of soft-tissue inflammation modulation; findings are preclinical and not predictive of human outcomes, and individual results vary

For research handling reference: the lyophilized peptide is typically reconstituted with bacteriostatic water (or sterile water) added slowly down the inner vial wall, then swirled gently rather than shaken until fully dissolved. Prior to reconstitution, store the sealed lyophilized vial in a cool, dry environment away from light; long-term storage of lyophilized material is generally kept frozen. After reconstitution, keep refrigerated, protect from light, and use within the period appropriate to the diluent and laboratory conditions. Avoid repeated freeze-thaw cycles and maintain aseptic technique throughout handling. All clinical protocols, dosing, frequency, and patient-suitability decisions are determined solely by the licensed ordering provider; this is reference information for professional and research use only and is not medical advice.

A per-lot Certificate of Analysis, HPLC purity profile, and mass-spectrometry verification are available on request for this product. Ask your account manager for the current lot documentation.

In the published preclinical literature, BPC-157 has been proposed to influence tissue-repair pathways in part through effects on angiogenesis, with research describing possible interaction with vascular endothelial growth factor (VEGF) signaling and nitric oxide (NO) pathway modulation. Some studies have additionally explored its proposed involvement in growth-factor receptor expression and fibroblast activity associated with connective-tissue remodeling. These mechanisms are reported in experimental and animal models and remain investigational; they are not established in humans, and individual results vary.